Core Products and Services

BMC will develop and produce therapeutics based on viruses, cells and antibodies for clients in academia and the pharmaceutical industry.

Products include:

• Oncolytic viruses
• Viral vectors for gene and cell therapy
• Vaccines
• Mesenchymal stem cells
• Somatic Cells
• Genetically-enhanced stem / progenitor cells

Services include:

• Innovation services that will expand the knowledge base on virus and cell manufacturing.
• Upstream and downstream process development.
• New assay development and assay qualification/validation services.
• cGMP manufacturing of clinical-scale virus products, cell banks, and individualized cell therapies.
• Development and execution of validated SOPs for clinical sample processing in accordance with the ICH Q2 guidelines.
• Stability and storage programs.
• Client cell line storage.
• GMP manufacturing of Master Cell Bank.
• Creation of viral master seed bank.
• Manufacturing process development, optimization and validation.
• Purification process development and optimization.
• Pilot virus batch manufacturing.
• GMP virus clinical lot manufacturing (bulk drug substance, drug product).
• Manufacturing and quality documentation (and regulatory support as needed).
• Co-development of virus-based therapeutics.